Clinical trials: LDL Cholesterol
LDL Cholesterol
Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction
Study to assess the LDL-C lowering efficacy of different doses of LIB003 administered every 4 weeks in subjects on stable statin and/or ezetimibe therapy
- Trial name
- NCT03549260
- Testing
- LIB003
- Where
- 5 sites in United States
- Volunteers
- 81 people
- Sponsor
- LIB Therapeutics LLC